Mike Baker

David Merryman, associate professor of biomedical engineering, found that a drug developed for rheumatoid arthritis stops a common binding protein from calcifying heart valves. (Vanderbilt University)
June 12, 2017

Drug developed for arthritis could be first to stop heart valve calcification

The first drug to treat calcification of heart valves may be one originally designed for rheumatoid arthritis.

By VUMC News and Communications